Prophylactic thyroidectomy in MEN IIA: Does the calcitonin level correlate with tumor spread?

Langenbeck's Archives of Surgery

Volumn 383, Issue 2, 1998, Pages 170-173

  Hotz, Hubert G ^a   Runkel, Norbert S F ^a   Frank Raue, Karin ^b   Raue, Friedhelm ^b   Buhr, Heinz J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

MEN IIA; Prophylactic thyroidectomy; Screening

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ADOLESCENT; ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER STAGING; CELL HYPERPLASIA; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MOLECULAR GENETICS; OCCULT CANCER; PRIORITY JOURNAL; PROPHYLAXIS; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

EID: 0031708781     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050112     Document Type: Article

References (21)

1. Koussef BG (1995) Multiple endocrine neoplasia 2 (MEN 2)/ MEN 2A (Sipple syndrome). Dermatol Clin 13. 91-97
2. Dralle H, Höppner W, Raue F (1996) Prophylaktische Thyroidektomie. Dtsch Arztebl 93: B-709-B-711
3. Frilling A, Stenger AM, Franz C, Padberg B, Broelsch CE (1995) Multiple endokrine Neoplasie - Erscheinungsbild, Diagnostik, chirurgische Therapie. Chir Gastroenterol 11: 28-33
4. Flier JS, Underhill LH (1996) The RET proto-oncogene in multiple endocrine neoplasia Type 2 and Hirschsprung's disease. N Engl J Med 335: 943-951
5. Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H (1995) Genetic testing in the diagnosis and management of multiple endocrine neoplasia Type II. Ann Int Med 122: 118-124
6. Raue F, Schmidt-Gayk H, Ziegler R (1983) Tumormarker beim C-Zell-Karzinom. Dtsch Med Wochenschr 108: 283-287
7. Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA (1996) Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2 A and 2 B. J Pediatr Surg 31: 177-182
8. Röher HD, Simon D, Goretzki PE, Höppner W, Lederbogen S, Seppel T (1995) Die prophylaktische Radikaloperation des C-Zell-Carcinomas beim MEN-II-Syndrom auf der Grundlage des genetischen Screening. Chirurg 66: 1196-1202
9. Tisell LE, Dilley WG, Wells SA (1996) Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 119: 34-39
10. Zink A, Blind E, Raue F (1992) Determination of serum calcitonin by immunometric two-site assay in normal subjects and patients with medullary thyroid carcinoma. Eur J Clin Chem Clin Biochem 30: 831-835
11. Buhr HJ, Raue F, Herfarth C (1991) Spezielle Tumorbiologie und Chirurgie des C-Zell-Carcinomas. Chirurg 62: 529-535
12. Vasen HFA, Vermey A (1995) Hereditary medullary thyroid carcinoma. Cancer Detect Prev 19: 143-150
13. Forster-Gibson CJ, Mulligan LM (1994) Multiple endocrine neoplasia type 2. Eur J Cancer 30A: 1969-1974
14. Ambrosch A, Pfützner A, Ponder BAJ, Beyer J, Luley C, Lehnert H (1995) Multiple endokrine Neoplasie Typ 2A. Genetisches Screening bei familiärem Tumorsyndrom. Dtsch Med Wochenschr 120: 615-619
15. Frilling A, Dralle H, Raue F, Broelsch CE (1995) Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery 118: 1099-1104
16. Goodfellow PJ, Wells SA (1995) RET gene and its implications for cancer. J Natl Cancer Inst 87: 1515-1523
17. Feldman GL, Kambouris M, Talpos GB, Mulligan LM, Ponder BAJ, Jackson CE (1994) Clinical value of direct DNA analysis of the RET proto-oncogene in families with multiple endocrine neoplasia type 2 A. Surgery 116: 1042-1047
18. Lairmore TC, Frisella MM, Wells SA (1996) Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma. Ann Med 28: 401-406
19. Lips CJM, Landsvater RM, Höppener JWM, Geerdink RA, Blijham G, Jansen-Schillhorn Van Veen JM, Van Gils APG, De Wit MJ, Zewald RA, Berends MJH, Beemer FA, Brouwers-Smalbraak J, Jansen RPM, Pools van Amstel HK, van Vroonhoven TJMV, Vroom TM (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2 A. N Engl J Med 331: 828-835
20. O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA (1994) Medullary thyroid carcinoma in multiple endocrine neoplasia types 2 A and 2 B. Surgery 116: 1017-1023
21. Wells SA, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBebedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia Type 2 A. Ann Surg 220: 237-250